BioCryst Pharmaceuticals Price Target Raised to $19.00/Share From $14.00 by HC Wainwright & Co.
BioCryst Pharmaceuticals Price Target Raised to $19.00/Share From $14.00 by HC Wainwright & Co.
DJ BioCryst Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.
Ratings actions from Benzinga: https://www.benzinga.com/stock/BCRX/ratings
(END) Dow Jones Newswires
March 24, 2021 06:48 ET (10:48 GMT)
DJ BioCryst Pharmaceuticals Price Target Raised to $19.00/Share From $14.00 by HC Wainwright & Co.
Ratings actions from Benzinga: https://www.benzinga.com/stock/BCRX/ratings
(END) Dow Jones Newswires
March 24, 2021 06:48 ET (10:48 GMT)
DJ BioCryst Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.
DJ BioCryst制药公司由HC Wainwright&Co.维持在Buy。
Ratings actions from Benzinga: https://www.benzinga.com/stock/BCRX/ratings
来自本辛加的评级行动:https://www.benzinga.com/stock/BCRX/ratings
(END) Dow Jones Newswires
(完)道琼通讯社
March 24, 2021 06:48 ET (10:48 GMT)
2021年3月24日东部时间06:48(格林尼治标准时间10:48)
DJ BioCryst Pharmaceuticals Price Target Raised to $19.00/Share From $14.00 by HC Wainwright & Co.
DJ BioCryst制药公司将目标价从每股14.00美元提高到19.00美元,由HC Wainwright&Co.
Ratings actions from Benzinga: https://www.benzinga.com/stock/BCRX/ratings
来自本辛加的评级行动:https://www.benzinga.com/stock/BCRX/ratings
(END) Dow Jones Newswires
(完)道琼通讯社
March 24, 2021 06:48 ET (10:48 GMT)
2021年3月24日东部时间06:48(格林尼治标准时间10:48)
译文内容由第三方软件翻译。
风险及免责提示
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧